Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Zhejiang Huazheng New Materials Co., Ltd. (hereinafter referred to as "Huazheng New Materials") was established in 2003 and is a controlling member enterprise of Huali Group. It is located in Hangzhou, Zhejiang Province and is one of the earliest enterprises in China to engage in research and development and production of epoxy resin copper clad laminates. On January 3, 2017, Huazheng New Materials (stock code: 603186) was officially listed on the A-share market of the Shanghai Stock Exchange, making it the first A-share listed company on the main board in Yuhang District. The company mainly designs, develops, produces, and sells products such as copper clad panels (including adhesive sheets), composite materials (including functional composite materials and composite materials for transportation and logistics), and aluminum plastic films for lithium battery soft packaging. The products are widely used in fields such as 5G communication, data exchange, new energy vehicles, smart home appliances, medical equipment, rail transit, and green logistics. As of now, Huazheng New Materials has 245 valid national patents, including 88 invention patents, 146 utility model patents, 11 appearance patents, and has led or participated in the development of 10 national and industry standards. So far, Huazheng New Materials has 10 subsidiaries and 7 main production bases, covering more than 100 countries and regions.
Headquarter Hangzhou
Establish Date 3/6/2003
Listed Code 603186.SH
Listed Date 1/3/2017
Chairman Liu Tao.
CEO Guo Jiangcheng.
Website www.wazam.com.cn

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial